Page last updated: 2024-08-17

egtazic acid and Carcinoma 256, Walker

egtazic acid has been researched along with Carcinoma 256, Walker in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castilho, RF; Degasperi, GR; Vercesi, AE	1

Other Studies

1 other study(ies) available for egtazic acid and Carcinoma 256, Walker

Article	Year
High susceptibility of activated lymphocytes to oxidative stress-induced cell death. Anais da Academia Brasileira de Ciencias, 2008, Volume: 80, Issue:1 Topics: Animals; Apoptosis; Calcium; Carcinoma 256, Walker; Chelating Agents; Deferoxamine; Egtazic Acid; Flow Cytometry; Lymphocyte Activation; Lymphocytes; Male; Membrane Potentials; Mitochondria; Nifedipine; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Siderophores; Spleen; tert-Butylhydroperoxide; Time Factors	2008

Article

Year

High susceptibility of activated lymphocytes to oxidative stress-induced cell death.

Anais da Academia Brasileira de Ciencias, 2008, Volume: 80, Issue:1

Topics: Animals; Apoptosis; Calcium; Carcinoma 256, Walker; Chelating Agents; Deferoxamine; Egtazic Acid; Flow Cytometry; Lymphocyte Activation; Lymphocytes; Male; Membrane Potentials; Mitochondria; Nifedipine; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Siderophores; Spleen; tert-Butylhydroperoxide; Time Factors

2008